Fresenius Kabi USA, LLC
Pharmaceutical & medical device company payment data from CMS Open Payments.
Total Payments
$9.8M
Doctors Paid
8,974
Transactions
22,091
2024 Total
$1.5M
Payment Breakdown by Category
Research$4.4M (45.0%)
Royalty/License$2.1M (21.8%)
Consulting$1.8M (18.3%)
Food & Beverage$512,766 (5.2%)
Travel$465,440 (4.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $4.4M | 410 | 45.0% |
| Royalty or License | $2.1M | 9 | 21.8% |
| Consulting Fee | $1.8M | 844 | 18.3% |
| Food and Beverage | $512,766 | 19,669 | 5.2% |
| Travel and Lodging | $465,440 | 959 | 4.7% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $191,484 | 74 | 1.9% |
| Honoraria | $122,556 | 53 | 1.2% |
| Space rental or facility fees (teaching hospital only) | $110,288 | 35 | 1.1% |
| Education | $42,980 | 16 | 0.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $15,480 | 15 | 0.2% |
| Charitable Contribution | $1,500 | 2 | 0.0% |
| Entertainment | $504.17 | 3 | 0.0% |
| Gift | $89.99 | 2 | 0.0% |
Payments by Type
General
$5.4M
21,681 transactions
Research
$4.4M
410 transactions
Research Studies & Clinical Trials
| Study Name | Total Paid | Doctors | Records |
|---|---|---|---|
| A Multicenter, Prospective, Controlled, Longitudinal-Cohort Study Assessing the Safety of Omegaven in Pediatric Patients with Parenteral Nutrition-Associated Cholestasis (PNAC) | $669,332 | 0 | 30 |
| Blood Center of Wisconsin | $426,970 | 0 | 36 |
| BCW Sponsored Master Agreement | $400,000 | 0 | 2 |
| SMOF-018-CP3 | $370,599 | 0 | 62 |
| In Vitro and In Vivo Evaluation of an Alternate Filter for the Alyx A200 Leukoreduction Filter | $283,198 | 0 | 6 |
| ARC Sponsored Master Agreement | $221,807 | 0 | 4 |
| Optimizing Recover in Trauma Patients: Integrating Enhanced Nutrition Delivery with Muscle Assessments, Functional Outcomes and Quality of Life | $162,000 | 0 | 2 |
| OMEG-035-IP3 | $150,229 | 0 | 3 |
| Univ of Cin study | $142,507 | 0 | 1 |
| Baylor College of Medicine-1 | $112,140 | 0 | 2 |
| Impact of SMOFlipid on Clinical Outcomes Among Patients Receiving Parenteral Nutrition | $94,000 | 0 | 1 |
| Boston Children | $92,517 | 0 | 1 |
| Cleveland Clinic Foundation | $73,450 | 0 | 2 |
| Duke University | $69,538 | 0 | 2 |
| SMOF-018-Walsh | $65,031 | 0 | 8 |
| HE06-019-IP4 | $65,000 | 0 | 1 |
| BCW Photopheresis Protocol | $64,570 | 0 | 2 |
| SMOF-018-Mascarenhas | $64,440 | 0 | 22 |
| ALYX-001-CMD / In Vitro and In Vivo Evaluation of an Alternate Filter for the ALYX A200 Leukoreduction Filter | $60,190 | 0 | 1 |
| SMOF-028-CP4 | $53,811 | 0 | 9 |
| SMOF-018-Robinson | $45,395 | 0 | 6 |
| Baylor College of Medicine-2 | $42,186 | 0 | 1 |
| SMOF-018-Ling | $41,191 | 0 | 12 |
| Effects of single and combined supplementation of glutamine and n-3 PUFAs on sepsis | $40,000 | 0 | 1 |
| Children's Hospital of Philadelphia | $38,814 | 0 | 19 |
| Duke IRB Pro102602 | $34,400 | 0 | 2 |
| Study Agreement Phoenix Children's | $29,961 | 0 | 1 |
| Evaluation of the Aurora Xi New Nomogram Software 2.0 | $27,200 | 1 | 7 |
| SMOF-018-Shores | $26,614 | 0 | 8 |
| American Red Cross | $26,157 | 0 | 4 |
Payments by Medical Specialty
Top Paid Doctors
| Doctor | Specialty | Location | Total | 2022 |
|---|---|---|---|---|
| Frank Strobl, Md, Phd, MD, PHD | Blood Banking & Transfusion Medicine | Garnet Valley, PA | $233,616 | $0 |
| Talat Ikizler, Md, MD | Nephrology | Nashville, TN | $213,593 | $0 |
| Robert Martindale, Md, MD | Surgery | Portland, OR | $174,957 | $0 |
| Michael Fitzgerald, Md, MD | Neonatal-Perinatal Medicine | Aurora, CO | $158,051 | $0 |
| Dr. David Evans, M.d, M.D | Surgical Critical Care | Columbus, OH | $113,719 | $0 |
| Dr. Jeffery Vender, Md, MD | Anesthesiology | Evanston, IL | $93,277 | $0 |
| Jack Pasquale, M.d, M.D | Internal Medicine | Fresh Meadows, NY | $83,348 | $0 |
| Dr. Zbigniew Szczepiorkowski, Md, Phd, MD, PHD | Blood Banking & Transfusion Medicine | Lebanon, NH | $81,139 | $0 |
| Andrea Kurz, Md, MD | Anesthesiology | Cleveland, OH | $74,196 | $0 |
| Dr. Kamyar Kalantar-Zadeh, M.d, M.D | Nephrology | Orange, CA | $55,887 | $0 |
| Naveen Mittal, Md, MD | Pediatric Gastroenterology | Dallas, TX | $44,962 | $0 |
| Paul Wischmeyer, Md, MD | Critical Care Medicine | Aurora, CO | $44,475 | $0 |
| John Marini, Md, MD | Pulmonary Disease | St Paul, MN | $38,590 | $0 |
| Dr. Martin Rosenthal, M.d, M.D | Surgery | Gainesville, FL | $34,605 | $0 |
| Dr. Manpreet Mundi, M.d, M.D | Endocrinology, Diabetes & Metabolism | Rochester, MN | $32,647 | $0 |
| Stephen Mcclave, Md, MD | Gastroenterology | Louisville, KY | $32,576 | $0 |
| Dr. John Mccullough, Md, MD | Blood Banking & Transfusion Medicine | Minneapolis, MN | $31,860 | $0 |
| Pampee Young, Md, Phd, MD, PHD | Anatomic Pathology & Clinical Pathology | Nashville, TN | $28,918 | $0 |
| Jimmy Morgan, Do, DO | Emergency Medicine | Joplin, MO | $28,000 | $0 |
| Darrell Triulzi | Specialist | Pittsburgh, PA | $25,743 | $0 |
| Tong Gan, M.d, M.D | Anesthesiology | Houston, TX | $25,572 | $0 |
| Dr. Claudia Cohn, M.d., Ph.d, M.D., PH.D | Anatomic Pathology & Clinical Pathology | Minneapolis, MN | $24,551 | $0 |
| Dr. Sivan Kinberg, M.d, M.D | Pediatric Gastroenterology | New York, NY | $24,483 | $0 |
| Satya-Krishna Ramachandran, Md, MD | Anesthesiology | Boston, MA | $24,079 | $0 |
| Mrs. Mona Papari, M.d, M.D | Blood Banking & Transfusion Medicine | Rosemont, IL | $22,710 | $0 |
Ad
Top Products
- OMEGAVEN $2.8M
- Smoflipid $1.5M
Associated Products (25)
- OMEGAVEN $2.8M
- Smoflipid $1.5M
- Amicus $940,619
- IDACIO $379,391
- MD-Other $362,272
- Omegaven $313,439
- PH-Omegaven $276,909
- SMOFLIPID $180,103
- Stimufend $112,082
- MD-Amicus $92,859
- Volume Therapy $86,456
- Amicus Separator $74,991
- PH-Icatibant $64,767
- Alyx Component Collection System $62,440
- PH-Smoflipid $49,545
- CATSmart $41,554
- Dilaudid $41,372
- Ketoanalogues $33,312
- Sodium Chloride $31,291
- Vitamin A $20,346
- Ivenix Infusion System $15,228
- SMOFLIPID 20% 100 G 500ML BAG $15,000
- Diphenhydramine $12,177
- Platelet Additive Solution $11,892
- Ketosteril $10,933
Payment Categories
- Food & Beverage $512,766
- Consulting $1.8M
- Travel & Lodging $465,440
- Research $4.4M
- Royalties $2.1M
About Fresenius Kabi USA, LLC
Fresenius Kabi USA, LLC has made $9.8M in payments to 8,974 healthcare providers, recorded across 22,091 transactions in the CMS Open Payments database. In 2024, the company paid $1.5M. The top product by payment volume is OMEGAVEN ($2.8M).
Payments were distributed across 159 medical specialties. The top specialty by payment amount is Blood Banking & Transfusion Medicine ($415,646 to 31 doctors).
Payment categories include: Food & Beverage ($512,766), Consulting ($1.8M), Research ($4.4M), Travel & Lodging ($465,440), Royalties ($2.1M).
Fresenius Kabi USA, LLC is associated with 25 products in the CMS Open Payments database, including OMEGAVEN, Smoflipid, and Amicus.